These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26375613)

  • 41. Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004.
    D'Angelo D; Williams L; Morrow B; Cox S; Harris N; Harrison L; Posner SF; Hood JR; Zapata L;
    MMWR Surveill Summ; 2007 Dec; 56(10):1-35. PubMed ID: 18075488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of oral fluconazole during pregnancy and the risk of birth defects.
    Mølgaard-Nielsen D; Pasternak B; Hviid A
    N Engl J Med; 2013 Aug; 369(9):830-9. PubMed ID: 23984730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study.
    Andersen SL; Lönn S; Vestergaard P; Törring O
    Eur J Endocrinol; 2017 Oct; 177(4):369-378. PubMed ID: 28780518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis.
    Shihab Z; Yeomans ND; De Cruz P
    J Crohns Colitis; 2016 Aug; 10(8):979-88. PubMed ID: 26755733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of breast cancer during pregnancy: an observational study.
    Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
    Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
    Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.
    Kanis SL; de Lima-Karagiannis A; de Boer NKH; van der Woude CJ
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1232-1241.e1. PubMed ID: 28342949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.
    Chen H; Wang Y; Lyu Q; Ai A; Fu Y; Tian H; Cai R; Hong Q; Chen Q; Shoham Z; Kuang Y
    Fertil Steril; 2015 May; 103(5):1194-1201.e2. PubMed ID: 25813280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptic ulcer disease with related drug treatment in pregnant women and congenital abnormalities in their offspring.
    Bánhidy F; Dakhlaoui A; Puhó EH; Czeizel AE
    Congenit Anom (Kyoto); 2011 Mar; 51(1):26-33. PubMed ID: 20727001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal pre-pregnancy body mass index and risk of selected birth defects: evidence of a dose-response relationship.
    Block SR; Watkins SM; Salemi JL; Rutkowski R; Tanner JP; Correia JA; Kirby RS
    Paediatr Perinat Epidemiol; 2013 Nov; 27(6):521-31. PubMed ID: 24117964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular malformations among preterm infants.
    Tanner K; Sabrine N; Wren C
    Pediatrics; 2005 Dec; 116(6):e833-8. PubMed ID: 16322141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assisted Reproductive Technology Surveillance - 
United States, 2013.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
    MMWR Surveill Summ; 2015 Dec; 64(11):1-25. PubMed ID: 26633040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.
    Seirafi M; de Vroey B; Amiot A; Seksik P; Roblin X; Allez M; Peyrin-Biroulet L; Marteau P; Cadiot G; Laharie D; Boureille A; De Vos M; Savoye G; Rahier JF; Carbonnel F; Bonaz B; Colombel JF; Bouhnik Y
    Aliment Pharmacol Ther; 2014 Aug; 40(4):363-73. PubMed ID: 24980270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maternal obesity and neonatal mortality according to subtypes of preterm birth.
    Nohr EA; Vaeth M; Bech BH; Henriksen TB; Cnattingius S; Olsen J
    Obstet Gynecol; 2007 Nov; 110(5):1083-90. PubMed ID: 17978123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use.
    Carman WJ; Accortt NA; Anthony MS; Iles J; Enger C
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1109-1118. PubMed ID: 28758274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A population-based cohort study of pregnancy outcomes among women with primary sclerosing cholangitis.
    Ludvigsson JF; Bergquist A; Ajne G; Kane S; Ekbom A; Stephansson O
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):95-100.e1. PubMed ID: 23891928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Women referred for occupational risk assessment in pregnancy have no increased risk of adverse obstetric outcomes.
    Bidstrup SB; Kaerlev L; Thulstrup AM; Bonde JP
    Dan Med J; 2015 Aug; 62(8):A5119. PubMed ID: 26239590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
    Meserve J; Luo J; Zhu W; Veeravalli N; Bandoli G; Chambers CD; Singh AG; Boland BS; Sandborn WJ; Mahadevan U; Singh S
    Gastroenterology; 2021 Jul; 161(1):107-115.e3. PubMed ID: 33744307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.